| 000 | 01887 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515130658.0 | ||
| 264 | 0 | _c20080902 | |
| 008 | 200809s 0 0 eng d | ||
| 022 | _a1526-632X | ||
| 024 | 7 |
_a10.1212/01.wnl.0000318277.25679.9e _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFu, Diana C | |
| 245 | 0 | 0 |
_aHigh-dose, rapid-infusion IVIG in postvaccination acute disseminated encephalomyelitis. _h[electronic resource] |
| 260 |
_bNeurology _cJul 2008 |
||
| 300 |
_a294-5 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCentral Nervous System _ximmunology |
| 650 | 0 | 4 |
_aCerebrospinal Fluid _xcytology |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aEncephalomyelitis, Acute Disseminated _xchemically induced |
| 650 | 0 | 4 |
_aGlucocorticoids _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xadministration & dosage |
| 650 | 0 | 4 |
_aImmunologic Factors _xadministration & dosage |
| 650 | 0 | 4 |
_aImmunosuppression Therapy _xmethods |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethylprednisolone Hemisuccinate _xadministration & dosage |
| 650 | 0 | 4 | _aMilitary Personnel |
| 650 | 0 | 4 | _aPhysical Therapy Modalities |
| 650 | 0 | 4 |
_aQuadriplegia _xchemically induced |
| 650 | 0 | 4 |
_aRecovery of Function _xdrug effects |
| 650 | 0 | 4 |
_aSmallpox Vaccine _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTyphoid-Paratyphoid Vaccines _xadverse effects |
| 650 | 0 | 4 |
_aVaccines _xadverse effects |
| 700 | 1 | _aMontgomery, Jay R | |
| 773 | 0 |
_tNeurology _gvol. 71 _gno. 4 _gp. 294-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/01.wnl.0000318277.25679.9e _zAvailable from publisher's website |
| 999 |
_c18125060 _d18125060 |
||